The Journal of the American Medical Association recently published a study of the impact of price transparency tools on healthcare spending at two large companies. Here are some key findings from the report:
·
Spending among
employees with a price transparency tool went from $2021 before the tool to
$2233.
·
Among controls, mean
outpatient spending changed from $1985 to $2138.
·
Being offered the tool
was associated with a mean $59 increase in outpatient spending.
·
Out-of-pocket spending
among those offered the tool was $507 in the year before and $555 the year
after.
·
Being offered the
transparency tool was associated with a $18 increase in out-of-pocket spending.
·
In the first 12
months, 10% of employees who were offered the tool used it at least once.
Source: JAMA, May 3, 2016
No comments:
Post a Comment